CONTENTS
Autumn 2022
Analytics
How can trapped ion mass spectrometry (TIMS) support advances in cellular biochemistry, and what could this mean for personalised medicine moving forwards?
What benefits to laboratories can be caused by new developments in visualisation technology, and how can they overcome issues associated with analysis?
New improvements in High Resolution Ion Mobility (HRIM) could impact the separation ability, throughput and reproducibility, and understanding of glycoprotein structures – what might this mean for researchers?
As technology within the analysis sphere continues to evolve, how can temperature control be better implemented during drug R&D and why is it becoming increasingly important?
Discovery & Development
The potential answers to this question are numerous. IPT asked representatives from across the pharma sector for their opinions, with answers including tools, assays, and improved collaboration.
Digital
Has the data collection that began during the COVID-19 pandemic across the pharma industry continued?
IPT discusses the digital innovations that are leading humancentred design with Dr Chris Vincent at PDD, and whether technologies like XR can be beneficial to the research process.
Concierge support services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
Manufacturing
Can advances made in nicotine delivery, such as in e-cigarette devices, be applied to the delivery of other active substances?
Lab Automation
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field.
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care.
Mikael Hagstroem, CEO of LabVantage Solutions, tells IPT about the ongoing potential for laboratories of adopting AI and machine learning (ML), and the benefits that this could bring across the development timeline.
Regulars
This issue of IPT calls attention to the potential of new opportunities, as in addition to the cutting-edge advancements across the pharma sector being discussed in the magazine, we also return with a brand new website, and lots of content to fill it.
This theme of new opportunities continues into the new year, with several exciting events taking place throughout the start of 2023.
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
Iona Everson
EDITORIAL ASSISTANTS
James Spargo
Betsy Goodfellow
EDITORIAL AND PRODUCTION ASSISTANT
Charlie Blackie-Kelly
George Grant
SALES
Helga Schweissguth
DESIGN
Peter May
FRONT COVER
SFC – Shutterstock.com
DIGITAL EDITION
by IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Hardings Print Solutions
www.hps-ltd.org.uk
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables, Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2022 Samedan Ltd
Pharmaceutical Publishers